Boothbay Fund Management’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $59.2K | Hold |
51,042
| – | – | ﹤0.01% | 1146 |
|
|
2025
Q1 | $56.1K | Hold |
51,042
| – | – | ﹤0.01% | 1107 |
|
|
2024
Q4 | $87.8K | Sell |
51,042
-666
| -1% | -$1.15K | ﹤0.01% | 1143 |
|
|
2024
Q3 | $128K | Sell |
51,708
-33,750
| -39% | -$83.7K | ﹤0.01% | 1237 |
|
|
2024
Q2 | $207K | Buy |
85,458
+33,750
| +65% | +$81.7K | ﹤0.01% | 1127 |
|
|
2024
Q1 | $209K | Sell |
51,708
-30,474
| -37% | -$123K | ﹤0.01% | 1157 |
|
|
2023
Q4 | $316K | Buy |
82,182
+20,997
| +34% | +$80.6K | 0.01% | 1013 |
|
|
2023
Q3 | $254K | Sell |
61,185
-65,921
| -52% | -$274K | 0.01% | 1146 |
|
|
2023
Q2 | $611K | Buy |
127,106
+62,580
| +97% | +$301K | 0.01% | 840 |
|
|
2023
Q1 | $262K | Buy |
64,526
+1,611
| +3% | +$6.54K | 0.01% | 1364 |
|
|
2022
Q4 | $340K | Buy |
62,915
+335
| +0.5% | +$1.81K | 0.01% | 1116 |
|
|
2022
Q3 | $628K | Buy |
62,580
+49,853
| +392% | +$500K | 0.02% | 969 |
|
|
2022
Q2 | $60K | Buy |
+12,727
| New | +$60K | ﹤0.01% | 1792 |
|